Development of Bone-Targeted Bortezomib to Treat Multiple Myeloma
Xing, Lianping, Wang, Hua, Xiao, L, Ebetino, F.H, Boeckman, R.K, Boyce, B.F
Published in Clinical lymphoma, myeloma and leukemia (01.02.2017)
Published in Clinical lymphoma, myeloma and leukemia (01.02.2017)
Get full text
Journal Article
Differentiating the mechanisms of antiresorptive action of nitrogen containing bisphosphonates
van Beek, E.R, Cohen, L.H, Leroy, I.M, Ebetino, F.H, Löwik, C.W.G.M, Papapoulos, S.E
Published in Bone (New York, N.Y.) (01.11.2003)
Published in Bone (New York, N.Y.) (01.11.2003)
Get full text
Journal Article
Characterisation of the interaction of nitrogen-containing bisphosphonates with human farnesyl pyrophosphate synthase (FPPS) using mutants of the lysine 200 and phenylalanine 239 active site residues
Tsoumpra, M.K, Barnett, B.L, Walters, R, Kwaasi, A.A, Ebetino, F.H, Oppermann, U, Russell, R.G, Dunford, J.E
Published in Bone (New York, N.Y.) (01.06.2010)
Published in Bone (New York, N.Y.) (01.06.2010)
Get full text
Journal Article
Use of hydroxyapatite-column chromatography combined with mass spectrometric analysis to assess the relative bone mineral-binding affinities of bisphosphonates at different PHS
Duan, X, Xia, Z, Zhang, H, Quijano, M, Dobson, R.L.M, Barnett, B, Triffitt, J.T, Dunford, J, Ebetino, F.H, Russell, R.G.G
Published in Bone (New York, N.Y.) (01.06.2010)
Published in Bone (New York, N.Y.) (01.06.2010)
Get full text
Journal Article
The direct antitumor activity of bisphosphonates in vivo depends on their bone mineral affinity
Fournier, P., Daubiné, F., Lundy ⁎, M.W., Ebetino ⁎, F.H., Clézardin, P.
Published in Bone (New York, N.Y.) (01.03.2006)
Published in Bone (New York, N.Y.) (01.03.2006)
Get full text
Journal Article
Evidence for the involvement of the threonine 201 side-chain in the interaction of nitrogen-containing bisphosphonates with farnesyl pyrophosphate synthase
Kwassi, A.A.A, Pilka, E.S, Evdokimov, A, Barnett, B.L, Ebetino, F.H, Russell, R.G.G, Kavanagh, K.L, Oppermann, U, Dunford, J.E
Published in Bone (New York, N.Y.) (01.06.2009)
Published in Bone (New York, N.Y.) (01.06.2009)
Get full text
Journal Article
The differential distribution in vivo of fluorescently-labeled bisphosphonate analogues with different mineral affinity to bone surfaces
Boyde, A, Lundy, M.W, Coxon, F.P, McKenna, C.E, Roelofs, A, Bala, J, Rogers, M.J, Blazewska, K, Russell, R.G.G, Ebetino, F.H
Published in Bone (New York, N.Y.) (01.05.2009)
Published in Bone (New York, N.Y.) (01.05.2009)
Get full text
Journal Article
Bone mineral affinity influences the distribution of a bisphosphonate and a lower affinity analogue in vivo
Roelofs, A.J, Boyde, A, Lundy, M.W, McKenna, C.E, Blazewska, K, Sun, S.T, Kashemirov, B.A, Russell, R.G.G, Ebetino, F.H, Rogers, M.J, Coxon, F.P
Published in Bone (New York, N.Y.) (01.06.2009)
Published in Bone (New York, N.Y.) (01.06.2009)
Get full text
Journal Article
Structure-activity relationships of bisphosphonate analogues
Coxon, F.P., Navea, J. Rojas, Stewart, C.A., Al Jaber, J., Ebetino ⁎, F.H., McKenna #, C.E., Kashemirov #, B.A., Mallard #, I., Rogers, M.J.
Published in Bone (New York, N.Y.) (01.03.2006)
Published in Bone (New York, N.Y.) (01.03.2006)
Get full text
Journal Article
Analogs of sub-nanomolar hMC1R agonist LK-184 [Ph(CH 2) 3CO-His- d-Phe-Arg-Trp-NH 2]. An additional binding site within the human melanocortin receptor 1?
Koikov, L.N, Ebetino, F.H, Solinsky, M.G, Cross-Doersen, D, Knittel, J.J
Published in Bioorganic & medicinal chemistry letters (02.08.2004)
Published in Bioorganic & medicinal chemistry letters (02.08.2004)
Get full text
Journal Article
Target enzyme specificity, potency and potential lack of side-effects of novel phosphonocarboxylate analogues of bisphosphonates
Coxon, F.P., Navea, J. Rojas, Stewart, C.A., Thompson, K., Roelofs, A., Ebetino ⁎, F.H., McKenna #, C.E., Kashemirov #, B.A., Bala #, J., Rogers, M.J.
Published in Bone (New York, N.Y.) (01.03.2006)
Published in Bone (New York, N.Y.) (01.03.2006)
Get full text
Journal Article
Novel insights into actions of bisphosphonates on bone: Differences in interactions with hydroxyapatite
Nancollas, G.H., Tang, R., Phipps, R.J., Henneman, Z., Gulde, S., Wu, W., Mangood, A., Russell, R.G.G., Ebetino, F.H.
Published in Bone (New York, N.Y.) (01.05.2006)
Published in Bone (New York, N.Y.) (01.05.2006)
Get full text
Journal Article
A computational model explains bisphosphonate binding affinity differences on hydroxyapatite
Ebetino, F.H., Barnett, B.L., Russell, R.G.G., Henneman, Z., Nancollas, G.H.
Published in Bone (New York, N.Y.) (01.03.2006)
Published in Bone (New York, N.Y.) (01.03.2006)
Get full text
Journal Article
Anti-nociceptive effects of the bisphosphonate risedronate in a syngeneic mouse model of bone cancer pain
Hald, A., Hansen, R.R., Sorensen, M. Wisbom, Ding, M., Kassem, M., Ebetino, F.H., Heegaard, A.M.
Published in Bone (New York, N.Y.) (01.03.2006)
Published in Bone (New York, N.Y.) (01.03.2006)
Get full text
Journal Article
Substitution of the R1 hydroxyl and C1 phosphate of risedronate produces differences in elution profiles on hydroxyapatite ceramic chromatographic columns
Xia, Z., Lawson, M.A., Triffitt, J.T., Ebetino, F.H., McKenna, C.E., Marma, M., Kashimirov, B, Russell, R.G.G.
Published in Bone (New York, N.Y.) (01.03.2006)
Published in Bone (New York, N.Y.) (01.03.2006)
Get full text
Journal Article